Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Central nervous system (CNS) tissue repair refers to the processes and strategies aimed at restoring structure and function to damaged CNS tissues, which include the brain and spinal cord. Unlike the peripheral nervous system, the CNS has a limited capacity for regeneration due to inhibitory factors in its environment, glial scarring, and restricted neurogenesis. The goal of CNS tissue repair is to replace lost neural cells, promote axonal regrowth, remyelinate axons, rebuild neural circuits, and ultimately restore neurological function.
Varies depending on the therapeutic strategy. Includes promoting neurogenesis, enhancing axonal regeneration, reducing glial scarring, modulating the immune response, and providing neurotrophic support.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Central Nervous System Tissue Repair (CNS Tissue Repair).